Literature DB >> 9702909

Effect of uteroplacental insufficiency upon brain neuropeptide Y and corticotropin-releasing factor gene expression and concentrations.

P A Rajakumar1, J He, R A Simmons, S U Devaskar.   

Abstract

Various hypothalamic functions such as feeding behavior, energy expenditure, body weight gain, level of anxiety, and sexual maturation are mediated by a balance between the concentrations of neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). To test the hypothesis that maternal uteroplacental insufficiency alters the offspring's brain NPY and/or CRF levels, we examined the effect of maternal uterine artery ligation with intrauterine growth restriction (IUGR) (p < 0.05) upon fetal (20 d) and postnatal (4, 14, and 21 d) brain NPY and CRF synthesis, concentrations, and regional distribution. An age-related increase in NPY (0.8 kb) and CRF (1.4 kb) mRNA levels with peak amounts at the 14-d postnatal age (p < 0.05) was observed. IUGR was associated with a 75% increase in fetal brain NPY mRNA levels (p < 0.05) with no change in NPY peptide, CRF mRNA and peptide amounts. Although the increase in NPY mRNA levels persisted postnatally (p < 0.05) at d 4 and 21, CRF mRNA amounts were 2.5-fold higher only in the 4-d IUGR (p < 0.05). Paralleling the mRNA changes, an age-related increase in RIA of NPY and CRF peptide concentrations was noted (p < 0.05). IUGR caused postnatal brain NPY and CRF peptide changes similar to corresponding mRNA levels (p < 0.05), despite normal postnatal circulating glucose, insulin, corticosterone, and leptin concentrations. The age-specific intergroup differences in the NPY and CRF peptide immunoreactivity appeared predominantly in the hypothalamic region. We conclude that maternal uteroplacental insufficiency causing IUGR leads to a pretranslational imbalance in the immediate (4 d) postnatal brain NPY and CRF peptide concentrations, thereby altering the developmental pattern. This alteration in NPY and CRF peptide concentrations, despite normalization of the metabolic milieu was associated with a persistent diminution in body weight. The IUGR-associated pretranslational increase in NPY and not CRF peptide levels at d 21, may herald changes in feeding behavior during the postsuckling phase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702909     DOI: 10.1203/00006450-199808000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

2.  Pre- and postnatal calorie restriction perturbs early hypothalamic neuropeptide and energy balance.

Authors:  Bo-Chul Shin; Yun Dai; Manikkavasagar Thamotharan; L Caroline Gibson; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2012-03-02       Impact factor: 4.164

Review 3.  Mechanisms affecting neuroendocrine and epigenetic regulation of body weight and onset of puberty: potential implications in the child born small for gestational age (SGA).

Authors:  Christian L Roth; Sheela Sathyanarayana
Journal:  Rev Endocr Metab Disord       Date:  2012-06       Impact factor: 6.514

Review 4.  Developmental and Transmittable Origins of Obesity-Associated Health Disorders.

Authors:  Arin K Oestreich; Kelle H Moley
Journal:  Trends Genet       Date:  2017-04-21       Impact factor: 11.639

5.  Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats.

Authors:  Karen M Moritz; Marc Q Mazzuca; Andrew L Siebel; Amy Mibus; Debbie Arena; Marianne Tare; Julie A Owens; Mary E Wlodek
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

Review 6.  Perinatal programming of obesity.

Authors:  Rebecca Simmons
Journal:  Semin Perinatol       Date:  2008-10       Impact factor: 3.300

7.  Strategies for reversing the effects of metabolic disorders induced as a consequence of developmental programming.

Authors:  M H Vickers; D M Sloboda
Journal:  Front Physiol       Date:  2012-07-02       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.